News | June 23, 2009

Medipattern Signs Breast CAD Deal with Long Island Radiology Associates

June 24, 2009 - The Medipattern Corp. reported that Long Island Radiology Associates (LIRA) has entered into a B-CAD-FOR-LIFE contract, in which B-CAD-FOR-LIFE will provide breast computer-aided diagnosis (CAD) to all seven of LIRA's facilities in the greater New York City area and on Long Island.

B-CAD-FOR-LIFE provides all of the separate components that are required to install, train, use and maintain B-CAD under one monthly service fee. Since its introduction in mid-February 2009, demand for this alternative, cost effective solution has steadily increased.

Current National Cancer Institute figures show that the breast cancer incidence rate for the two counties on Long Island are elevated by 8.5 percent to 11.7 percent higher than the U.S. national average(1). The practices on Long Island are operating in an environment where the odds are stacked against their patients and they strive to take full advantage of technology to help them find and correctly identify breast cancer earlier while it is more treatable.

The Medipattern Corporation will show B-CAD-FOR-LIFE at the following 2009 events:
- BIC (Breast Imaging Conference), September 4-5, 2009 in Nashville, Tenn., partnered with GE
- International Breast Symposium, October 1-4, 2009 in Chicago, Ill.
- RSNA (Radiological Society of North America), November 29 to December 3, 2009, Chicago, Ill.

(1) According to National Cancer Institute data, the U.S. national breast
cancer incidence rate is 127.8 per 100,000 patients. Nassau County
exceeds the U.S. national incidence rate by 10.9 cases per 100,000,
and Suffolk County exceeds it by 14.9 cases per 100,000.

For more information: www.medipattern.com

Related Content

Videos | Artificial Intelligence | December 13, 2018
ITN Editor Dave Fornell and ITN Contributing Editor Greg Freiherr share their insights on the vendors showing...
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
Infervision Introduces AI Capabilities for Chest CT Reading
Technology | Computer-Aided Detection Software | November 30, 2018
Big data and artificial intelligence (AI) company Infervision announced the launch of InferRead CT Chest, a new product...
NeuroLogica and MaxQ AI Announce Distribution Agreement
News | Stroke | November 30, 2018
Clinical diagnostics intelligence platform company MaxQ AI and Samsung NeuroLogica announced a distribution agreement...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Arterys Demonstrates AI Cloud-Based Medical Image Analysis Solutions at RSNA 2018
News | Computer-Aided Detection Software | November 26, 2018
Medical imaging software company Arterys will demonstrate its wide-ranging suite of artificial intelligence (AI)-...
QView Medical Showcases QVCAD for ABUS Exams at RSNA 2018
News | Ultrasound Women's Health | November 19, 2018
QView Medical will showcase QVCAD, the first U.S. Food and Drug Administration (FDA)-approved artificial intelligence (...
Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...